Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ariva “Cigalett” Pieces Are Foods, Not Smokeless Tobacco Items, GSK Says

This article was originally published in The Tan Sheet

Executive Summary

Star Scientific's Ariva "cigalett" pieces and other candy-like products containing tobacco do not fall within the definition of smokeless tobacco products, GlaxoSmithKline says in a citizen petition filed with FDA Feb. 15

You may also be interested in...



Nicowater OTC Homeopathic Remedy Classification Illegal – GSK

QT5's Nicowater nicotine beverage cannot legally be marketed as an over-the-counter homeopathic product because it contains "too great a concentration of nicotine," GSK asserts in a March 21 1citizen petition filed by Washington, D.C. law firm Ropes & Gray

Nicowater OTC Homeopathic Remedy Classification Illegal – GSK

QT5's Nicowater nicotine beverage cannot legally be marketed as an over-the-counter homeopathic product because it contains "too great a concentration of nicotine," GSK asserts in a March 21 1citizen petition filed by Washington, D.C. law firm Ropes & Gray

Nicowater OTC Homeopathic Remedy Classification Illegal – GSK

QT5's Nicowater nicotine beverage cannot legally be marketed as an over-the-counter homeopathic product because it contains "too great a concentration of nicotine," GSK asserts in a March 21 1citizen petition filed by Washington, D.C. law firm Ropes & Gray

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093681

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel